Main navigation

Products we regulate
Product safety
How we regulate
Guidance and resources

Apotex Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1354)
Cancellation or suspension (47)
Prescription medicine registration (18)
ARTG (8)
Australian Public Assessment Report (AusPAR) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2024 (4)
2023 (16)
2022 (159)
2021 (104)
2020 (216)
2019 (124)
2018 (380)
2017 (307)
2016 (37)
2015 (52)
2014 (32)

Results for "[search-keyword]"

Search

Sponsor content

1431 result(s) found, displaying 781 to 790

Blooms the Chemist Amlodipine/Atorvastatin 10/20 amlodipine and atorvastatin 10mg/20mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
Blooms the Chemist Amlodipine/Atorvastatin 10/40 amlodipine and atorvastatin 10mg/40mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
Blooms the Chemist Amlodipine/Atorvastatin 5/80 amlodipine and atorvastatin 5mg/80mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
Blooms the Chemist Amlodipine/Atorvastatin 5/10 amlodipine and atorvastatin 5mg/10mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
Blooms the Chemist Amlodipine/Atorvastatin 10/10 amlodipine and atorvastatin 10mg/10mg film-coated tablet blister pack Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
KETOROLAC APOTEX ketorolac trometamol 10 mg/1 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
GenRx KETOROLAC ketorolac trometamol 10 mg/1 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
GenRx KETOROLAC ketorolac trometamol 30 mg/1 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
KETOROLAC APOTEX ketorolac trometamol 30 mg/1 mL solution for injection ampoule Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd
APO-CABERGOLINE cabergoline 500 micrograms tablets bottle Cancelled under Section 30(1)(c) of the Act

13 June 2018

Cancellation by sponsor

Requested by Apotex Pty Ltd

Pages

First page
Previous page
…
Page 75
Page 76
Page 77
Page 78
Current page 79
Page 80
Page 81
Page 82
Page 83
…
Next page
Last page

Is there anything wrong with this page?

Help us improve the Therapeutic Goods Administration site

What were you doing? (mandatory)

What went wrong? (mandatory)

Leave this field blank

Using our website

Accessibility
Privacy
Disclaimer
Copyright
Freedom of information

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Subscribe to updates
Contact us
Facebook
(Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health and Aged Care acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.